News
Big Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no ...
Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...
The best-financed lobbyists in the United States are protecting the pharmaceutical sector, but that may change ...
When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...
Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.
Hosted on MSN15d
Big pharma braces for revenue headwinds as patent expiries loomIn May 2025, the US president signed an executive order that overhauled pharmaceutical pricing in ... formulations as ...
Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...
Missourians simply cannot afford their prescription drugs. More than one in four have skipped doses or split pills to make prescriptions last longer. Over half worry they won’t be able to afford their ...
9d
NDTV Profit on MSNTCS Order Pipeline Robust But Demand Woes Persist, Says CEO K KrithivasanKrithivasan highlighted the mixed nature of demand growth for the company, where auto and telecom segments are muted and ...
In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...
11d
Stocktwits on MSNTrump Threatens 200% Tariffs On Drug Imports, Says Big Pharma Will Get Some Time 'To Get Their Act Together'U.S. President Donald Trump on Tuesday threatened to impose tariffs as high as 200% on pharmaceuticals imported into the ...
In the first part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results